Trials / Terminated
TerminatedNCT00818090
Paclitaxel and Cisplatin for Thymic Neoplasm
A Phase II Study of Paclitaxel and Cisplatin in Previously Untreated, Unresectable Invasive Thymoma or Thymic Carcinoma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Korean Cancer Study Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and safety of the regimen in previously untreated, unresectable invasive thymoma or thymic carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paclitaxel and cisplatin | paclitaxel and cisplatin every 3 weeks |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2009-01-07
- Last updated
- 2013-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00818090. Inclusion in this directory is not an endorsement.